BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy. - Perez-Garcia, Georgina; Bicak, Mesude; Haure-Mirande, Jean-Vianney; Perez, Gissel M.; Otero-Pagan, Alena; Gama Sosa, Miguel A.; De Gasperi, Rita; Sano, Mary; Barlow, Carrolee; Gage, Fred H.; Readhead, Benjamin; Ehrlich, Michelle E.; et al. (Neuroscience Letters, 2023)